Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plant. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksChill Brands Regulatory News (CHLL)

Share Price Information for Chill Brands (CHLL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2.55
Bid: 2.40
Ask: 2.70
Change: 0.25 (10.87%)
Spread: 0.30 (12.50%)
Open: 2.30
High: 2.70
Low: 2.25
Prev. Close: 2.30
CHLL Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Appointment of Strategic Advisor

30 Sep 2021 07:30

RNS Number : 5148N
Chill Brands Group PLC
30 September 2021

For immediate release

30 September 2021

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF REGULATION 11 OF THE MARKET ABUSE (AMENDMENT) (EU EXIT) REGULATIONS 2019/310

Chill Brands Group PLC

('Chill', the 'Company' or the 'Group')

Appointment of Strategic Advisor

ChillBrandsGroupplc(LON:CHLL)(OTCQX:ZOEIF),the international CBD group,ispleasedtoannounce the appointment of Viridian Capital Advisors as a strategic advisor in connectionwith capital raising strategy, M&A strategy, development of its board of directors and investor relations.

Highlights

In June 2014, Viridian Capital Advisors ("Viridian" or "VCA") was founded as one of the first financial and strategic advisory firms in the US cannabis/hemp industry, with a team of seasoned advisors, investment bankers and analysts.

Viridian's Board of Advisors is comprised of senior executives from some of the largest brand companies in the world, including Diageo, Proctor & Gamble, Anheuser Busch, Mars Wrigley and Philip Morris.

VCA has been engaged by some of the best of breed emerging growth companies in the US cannabis/hemp industry.

Viridian is widely quoted by the mainstream media as an expert in the cannabis/hemp industry, including Reuters, CNN, Forbes, Bloomberg, and the Wall Street Journal.

Viridian's President, Scott Greiper, will address shareholders during the Company's Annual General Meeting that is being held later today.

Chill's advisory agreement with Viridian is focused on building the business, profile, market value and liquidity of the Company.

As part of the agreement, Viridian has today been issued warrants exercisable into 4.9% of the Company's fully diluted ordinary share capital (representing approximately 11,290,826 ordinary shares), with an exercise period of five years and an exercise price of 1 pence per ordinary share of 1 pence each ("Ordinary Shares"), which are exercisable on the Company's Ordinary Share price appreciating to 60 pence, or otherwise, exercisable at 25% per quarter following the 12 month anniversary of the grant date.

Scott Greiper, Founder and President of Viridian Capital will be leading the engagement with the Company (not a Board position). Mr. Greiper has had a highly successful 30-year career on Wall Street and in his own businesses, with a track record of helping to identify, advise, finance and buy/sell best of breed emerging growth companies in newly emerging industries. Mr. Greiper attended the Executive MBA programme at Columbia University and received his B.A. in Economics from the University of Chicago.

Scott Greiper will address the Company's shareholders as part of a presentation during the Company's Annual General Meeting which is being held in Colorado at 4pm BST today.

TrevorTaylor,Co-CEOofChillBrandsGroup,said:"WearedelightedtowelcomeScott Greiper and Viridian Capital Advisors to Chill Brands Group and are excited to draw on their extensive experience, network and global following. Global brand building requires world-class talent and capital, and we are pleased to have gained support fromprofessionalsof sucha highcalibre. We look forward to hearing Scott speak at our AGM and are optimistic for the future."

- Ends -

Media enquiries:

Chill Brands Group plc

c/o Buchanan

Trevor Taylor, Co-CEO

Antonio Russo, Co-CEO

Allenby Capital Limited (Financial Adviser and Broker)

+44 (0) 20 3328 5656

Nick Harriss / Nick Naylor (Corporate Finance)

Kelly Gardiner (Equity Sales)

Buchanan

Henry Harrison-Topham / Jamie Hooper / Ariadna Peretz

Tel: +44 (0) 20 7466 5000

chillbrands@buchanan.uk.com

www.buchanan.uk.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
MSCURUVRAOUKORR
Date   Source Headline
13th Sep 20224:41 pmRNSSecond Price Monitoring Extn
13th Sep 20224:36 pmRNSPrice Monitoring Extension
1st Sep 20223:45 pmRNSNotice of AGM
18th Aug 20227:00 amRNSAgreement for CBD Distribution Support
17th Aug 20224:41 pmRNSSecond Price Monitoring Extn
17th Aug 20224:35 pmRNSPrice Monitoring Extension
3rd Aug 20227:00 amRNSUpdate on Synthetic Nicotine Products
29th Jul 20225:00 pmRNSTotal Voting Rights & Holdings in the Company
13th Jul 20224:40 pmRNSSecond Price Monitoring Extn
13th Jul 20224:35 pmRNSPrice Monitoring Extension
4th Jul 20221:00 pmRNSIssue of Equity
30th Jun 20225:00 pmRNSTotal Voting Rights
23rd Jun 20227:00 amRNSAcquisition of Chill.com Domain Complete
21st Jun 20227:00 amRNSAdmission of New Shares & Total Voting Rights
17th Jun 20222:30 pmRNSResult of Open Offer
31st May 20225:00 pmRNSTotal Voting Rights
31st May 20227:00 amRNSOpen Offer to Shareholders
27th May 20225:30 pmRNSIssue of Equity
12th May 202210:17 amRNSResult of General Meeting
12th May 20229:30 amRNSBusiness Update
9th May 20227:00 amRNSProposed Open Offer
29th Apr 20225:30 pmRNSTotal Voting Rights
29th Apr 202211:00 amRNSPrice Monitoring Extension
27th Apr 20222:06 pmRNSSecond Price Monitoring Extn
27th Apr 20222:00 pmRNSPrice Monitoring Extension
26th Apr 20224:36 pmRNSCompany Raises £3.5m & Notice of GM
22nd Apr 202211:05 amRNSSecond Price Monitoring Extn
22nd Apr 202211:00 amRNSPrice Monitoring Extension
21st Apr 20227:00 amRNSIssue of Shares to Marketing Partner
20th Apr 20227:30 amRNSIssue of Shares to Director
19th Apr 20224:35 pmRNSPrice Monitoring Extension
19th Apr 20227:00 amRNSAppointment of CEO & Board Changes
4th Apr 20222:05 pmRNSSecond Price Monitoring Extn
4th Apr 20222:00 pmRNSPrice Monitoring Extension
22nd Mar 20224:41 pmRNSSecond Price Monitoring Extn
22nd Mar 20224:36 pmRNSPrice Monitoring Extension
15th Mar 20227:00 amRNSUpdate re Outstanding Promissory Note
14th Mar 202211:05 amRNSSecond Price Monitoring Extn
14th Mar 202211:00 amRNSPrice Monitoring Extension
9th Mar 202211:05 amRNSSecond Price Monitoring Extn
9th Mar 202211:00 amRNSPrice Monitoring Extension
4th Mar 20224:41 pmRNSSecond Price Monitoring Extn
4th Mar 20224:36 pmRNSPrice Monitoring Extension
4th Mar 20227:30 amRNSTrading Update
9th Feb 20228:00 amRNSChill Partners with Micro-Fulfilment Provider
7th Feb 20229:15 amRNSHolding(s) in Company
1st Feb 20227:00 amRNSHolding(s) in Company
31st Jan 20224:41 pmRNSSecond Price Monitoring Extn
31st Jan 20224:36 pmRNSPrice Monitoring Extension
31st Jan 20229:05 amRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.